Ads
related to: ptsd
Search results
Service dogs helped ease PTSD symptoms in US military veterans, researchers say
Associated Press· 2 days agoSpecially trained service dogs helped ease PTSD symptoms in U.S. military veterans in a small study...
FDA panel votes against MDMA for PTSD, setting up hurdle to approval
CBS News· 1 day agoThe committee voted nine against, two in favor, on the question of whether there was enough data to...
FDA objects to ecstasy for treating PTSD patients
The Washington Times· 15 hours agoLykos Therapeutics and the Multidisciplinary Association for Psychedelic Studies tested the psychedelic drug, which can heighten feelings of intimacy and...
FDA advisers consider MDMA therapy to treat PTSD
WAAY-TV Huntsville· 2 days agoIt’s the first time the FDA’s advisers have considered a psychedelic drug for medical use. The novel treatment has the potential to transform a field...
Boston doctor weighs on using psychedelic drugs to treat PTSD
WCVB Boston· 9 hours agoCARDIO MYOPATHY AND ADVISORY GROUP FOR THE FDA HAS VOTED AGAINST USING PSYCHEDELIC DRUGS TO TREAT...
FDA panel rejects ecstasy to treat PTSD
The Week via Yahoo News· 14 hours agoThe committee voted 9-2 that data submitted by Lykos Therapeutics did not prove that MDMA combined with talk therapy was effective at treating PTSD. Who...
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
seattlepi.com· 1 day agoA first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was...
U.S. health experts vote against MDMA as treatment for PTSD
The Raw Story· 18 hours agoA panel of U.S. health experts convened by the Food and Drug Administration on Tuesday...
FDA advisory panel fails to endorse psychedelic MDMA therapy for PTSD (NASDAQ:CMPS)
Seeking Alpha· 1 day agoA panel of FDA advisors declined to endorse Lykos Therapeutics application for MDMA as a PTSD...
FDA panel rejects first MDMA-based PTSD treatment
USA Today· 1 day agoThe panel voted 10-to-1 against the therapy, saying the benefits did not outweigh its risks, while nine of the 11 members said the available data did not...
